118
Views
29
CrossRef citations to date
0
Altmetric
Review

Food protein-induced enterocolitis syndrome – a review of the literature with focus on clinical management

, , &
Pages 197-207 | Published online: 27 Jun 2017

Abstract

Food protein-induced enterocolitis syndrome (FPIES) is a potentially severe presentation of non-IgE-mediated gastrointestinal food allergy (non-IgE-GI-FA) with heterogeneous clinical manifestations. Acute FPIES is typically characterized by profuse vomiting and lethargy, occurring classically 1–4 hours after ingestion of the offending food. When continuously exposed to the incriminated food, a chronic form has been described with persistent vomiting, diarrhea, and/or failure to thrive. Although affecting mainly infants, FPIES has also been described in adults. Although FPIES is actually one of the most actively studied non-IgE-GI-FAs, epidemiologic data are lacking, and estimation of the prevalence is based on a limited number of prospective studies. The exact pathomechanisms of FPIES remain not well defined, but recent data suggest involvement of neutrophils and mast cells, in addition to T cells. There is a wide range of food allergens that can cause FPIES with some geographical variations. The most frequently incriminated foods are cow milk, soy, and grains in Europe and USA. Furthermore, FPIES can be induced by foods usually considered as hypoallergenic, such as chicken, potatoes or rice. The diagnosis relies currently on typical clinical manifestations, resolving after the elimination of the offending food from the infant’s/child’s diet and/or an oral food challenge (OFC). The prognosis is usually favorable, with the vast majority of the case resolving before 5 years of age. Usually, assessment of tolerance acquisition by OFC is proposed every 12–18 months. Of note, a switch to an IgE-mediated FA is possible and has been suggested to be associated with a more severe phenotype. Avoiding the offending food requires education of the family of the affected child. A multidisciplinary approach including ideally allergists, gastroenterologists, dieticians, specialized nurses, and caregivers is often useful to optimize the management of these patients, that might be difficult.

Introduction

Food protein-induced enterocolitis syndrome (FPIES) is a severe presentation of non-IgE-mediated food allergy affecting the gastrointestinal (GI) tract mainly in infants and young children.Citation1,Citation2 This syndrome is typically characterized by profuse vomiting and lethargy, occurring classically 1–4 hours after ingestion of the offending food.Citation3 Diagnosis of FPIES is difficult, and misdiagnosis is common.Citation4,Citation5 There are a number of differential diagnosis that should be ruled out. Thus, FPIES is often confounded with sepsis, metabolic diseases, severe gastroenteritis, or even abdominal surgical emergencies before reaching a final diagnosis.Citation6 Recent studies have suggested that FPIES is not as rare as previously believed.Citation4,Citation6Citation8 But despite increased interest, our understanding of its pathomechanism remains limited, and many management aspects are still highly debated, including emerging recommendations regarding the introduction of new foods in FPIES patients and follow-up.

In this review we will discuss the epidemiology, clinical characteristics, incriminated foods, pathomechanisms, diagnosis, and differential diagnosis of FPIES, with a particular focus on management aspects.

Epidemiology

Although FPIES was initially described in the 1940s, a limited number of studies have been published until the recent surge in interest.Citation9 Currently, FPIES is one of the most actively studied non-IgE-mediated GI food allergies (non-IgE-GI-FAs).Citation10 Epidemiologic data are lacking, and estimation of the prevalence is based on a limited number of prospective studies.Citation7,Citation11 Thus, a prospective birth cohort study conducted over 2 years in Israel reports a 0.34% prevalence of FPIES to cow’s milk (CM) and 0.5% IgE-mediated FA to CM in the same study cohort.Citation7 These results were quite surprising, as the prevalence of FPIES was believed to be much lower than the one of IgE-mediated allergy. Another prospective study cohort conducted through a national register in Australia showed an incidence of 1/10,000 cases per year including all different food triggers.Citation11 However, this lower incidence is likely to be underestimated due to methodological issues.Citation5

FPIES can present at all ages, with a slight male predominance.Citation5 In contrast to eosinophilic esophagitis, there is no strong familial association in both parents and siblings.Citation12,Citation13 However, association with atopic diseases is commonly reported, particularly atopic dermatitis (up to 57%).Citation14,Citation15 Other atopic diseases such as allergic rhinitis, asthma, IgE-mediated FA, and eosinophilic esophagitis or gastroenteritis might also be infrequently associated.Citation4,Citation12,Citation16 Katz et al, observed that infants with CM-FPIES were more often delivered by c-section, suggesting a role for intestinal microbiota in the development of FPIES.Citation7 However, these data have not been confirmed afterwards.

Further epidemiologic data are needed in the future, not only to have an accurate estimate of the prevalence in different countries, but also to identify risk factors to develop FPIES.

Clinical manifestations

FPIES is classical described as chronic or acute.Citation17,Citation18 In the chronic form, as initially described by Powell, patients typically present with chronic intermittent emesis, diarrhea with blood or mucus, abdominal distension, and/or lethargy. In the most severe cases patients progress to dehydration, metabolic abnormalities, nutritional deficiencies, and failure to thrive (FTT). In some cases, even older children can present with chronic FPIES in case of frequent repetitive solid food ingestion.Citation19 However, chronic FPIES remains not well defined and due to its aspecific clinical symptoms, the diagnosis is often difficult, particularly as symptoms may overlap with other non-IgE-GI-FAs mediated allergy (food protein-induced enteropathy [FPE] and food protein-induced allergic proctocolitis [FPIAP]). In addition, the literature regarding this disorder is poor and most of the currently published studies did not include a confirmatory oral food challenge (OFC). Moreover, some authors have been speculated that chronic FPIES might be a separate disease entirely, not just a different presentation.Citation20

Acute FPIES is typically characterized by repetitive profuse vomiting (90%–100%), pallor (14%–67%), and/or lethargy (3%–85%), typically occurring 1–4 hours after ingestion of the offending food.Citation2,Citation10 Diarrhea may follow 5–10 hours later, in up to 50% of infants and in only 30% of children older than 1 year of age.Citation2,Citation4,Citation7,Citation10 Hypotension in FPIES has been reported in up to 15% of patients in some series.Citation7,Citation10,Citation12,Citation16 Of note, acute FPIES can be the initial presentation or may occur after a period of exclusion in patients with chronic FPIES after reintroduction of the offending food (acute-on-chronic form). In the vast majority of cases, the first reaction appears after the first or second ingestion of the causative food.Citation4 Although chronic form of FPIES may occur in breastfed infants, the acute form has been rarely described in exclusively breastfed infants.Citation5,Citation6

The age at presentation for the acute form is variable and may depend on the offending food. Thus, it has been shown that FPIES to solids typically appears later than FPIES to CM or soy, probably owing to the timing of solid foods introduction into the diet.Citation2,Citation12 But other factors (i.e., environmental and genetic) probably influence the development of FPIES. Adult onset FPIES to fish and/or shellfish is an example of FPIES, probably unrelated to delayed food introduction.Citation12,Citation21

Pathophysiology

FPIES is typically classified as a non-IgE-GI-FA, but its exact pathomechanisms remain not well defined.

Several studies have suggested a key role for T cells in FPIES patients, particularly by founding positive patch test or positive lymphocyte transformation test to the specific food allergen.Citation22Citation28 It has been suggested that secretion of proinflammatory cytokines TNF-α and IFN-γ, in combination with a relative lack of expression of TGF-β-receptors (known as a protector of the intestinal wall) may contribute to local inflammation and increased intestinal permeability.Citation16,Citation29Citation31 Nevertheless, it has been shown that neither peripheral blood mononuclear cell proliferation nor patch tests can be used as a diagnostic tool at an individual level, questioning the role of T cell in FPIES patients.Citation22Citation26,Citation29 The role of these cells has been further challenged by recent data showing similar CD4+ T cell-proliferative responses after casein stimulation in CM FPIES patients to those with IgE-mediated CM allergy and those tolerating CM.Citation32

The mechanism of tolerance acquisition in FPIES remains unclear. CD4+CD25+ regulatory T cells might be implicated, as they have been increasingly identified in infants/children who acquired tolerance to the incriminated food.Citation33 It is hypothesized that they exert a suppressive action via cell to cell contact and by the production of TGF-β and IL-10.Citation26,Citation33 Recently, data support the suggested key role of IL-10 in acquisition of tolerance in patients with CM FPIES.Citation32

The role of neutrophils has also been discussed, as they typically increase after ingestion of the incriminated food, peaking at 6 hours.Citation18 In addition, neutrophils have been found in gastric aspirate and stool mucus in patients with FPIES, as well as in biopsies from FPIES patients. An increase of serum IL-8 levels after positive OFC also suggested a key role of these cells.Citation32 However, their role in the pathomechanism of FPIES has not been clearly demonstrated; the rise in peripheral neutrophil count could simply reflect unspecific stress response or the side effect of steroid administration as treatment.Citation1,Citation4,Citation17,Citation18,Citation34 From another point of view, eosinophils have been found in biopsies from FPIES patients, suggesting a potential involvement of these cells.Citation35,Citation36 Recently, a potential role of mast cells has been suggested, but these data need to be confirmed by further studies.Citation32

Although FPIES is typically categorized as a non-IgE mediated allergic disorder, some FPIES patients may have positive specific IgE to the causal protein either at onset or during follow-up; this is referred to as “atypical FPIES”.Citation12,Citation19,Citation37 Of note, a switch from the non-IgE to an IgE phenotype, or the opposite is possible, and the relation between non-IgE-GI-FA and IgE-mediated FA required further investigation.Citation2,Citation33,Citation37

The observed increase of specific IgA and IgG antibodies in patients with FPIES has raised the question of a humoral response in this disorder.Citation24,Citation34,Citation38 However, recent study suggests that their role is probably limited.Citation32

Further studies are needed to better understand the pathomechanism of this disease. Recent pathological findings are summarized in .

Table 1 Summary of our current understanding of the pathophysiology of FPIES

Offending foods

There is a wide range of food allergens that can cause FPIES. In Europe and USA, the most frequently incriminated foods are CM, soy, and grains.Citation5Citation8,Citation15,Citation16,Citation20,Citation39Citation41 Furthermore, FPIES can be induced by foods usually considered as hypoallergenic, such as meat, white and sweet potatoes, chicken, mushrooms, fruits and vegetables.Citation2Citation4,Citation6,Citation15,Citation16,Citation19,Citation20,Citation39Citation47 There are some geographical variations regarding the frequency of incriminated foods in FPIES that are summarized in . These differences may be related to country-specific food habits, in particular differences in the timing of food-introduction in infancy.Citation2,Citation20,Citation48 Thus, FPIES to CM and soy commonly appear in the first 3 months of life. It has been recently suggested that early introduction of CM or soy formula is a risk factor for the development of CM or soy FPIES, respectively.Citation2 American infants have a lower rate of breastfeeding and are earlier exposed to formula CM than Australian infants.Citation5 In Australia and Europe soy formula is rarely used in the first 24 months of life, whereas soy formula is frequently used in the USA even before 6 months of life.Citation11,Citation49 This might explain, at least partially, the relatively high prevalence of FPIES to soy in USA compared to other countries. In Australia chicken is one of the first solid foods introduced in the child’s diet, which might explain why FPIES to chicken appears earlier in Australia compared to USA where only 28% of the children under 6 months have tried chicken.Citation11,Citation50

Table 2 Distribution of offending food for FPIES in different countries

Most children react to a single food (i.e., 65%–80%).Citation10 Nevertheless, FPIES to multiple foods is not uncommon and the prevalence seems to vary geographically.Citation4,Citation6,Citation7 Thus, it has been shown that a significant proportion of infants with FPIES to CM or soy (i.e., 37%–50%) will also react to soy or CM respectively, as well as to other foods (19%).Citation8,Citation20,Citation23,Citation51 However, these associations have not been found in other studies.Citation4,Citation6,Citation7 FPIES to multiple solid foods has also been particularly described in infants with FPIES to grains.Citation2,Citation14 Indeed, infants with FPIES to grains such as rice, oat, or barley are particularly at risk of developing FPIES to other grains.Citation2,Citation20 In American studies, it has been shown that concomitant FPIES to oat and rice can occur in up to 35–44% of patients with FPIES to oat or rice.Citation2,Citation14 However, the proportion of FPIES to multiple solid foods was significantly lower in studies outside USA. Higher proportion of patients reacting to multiple foods in USA might also be explained by inclusion of more severe cases recruited in tertiary centers, compared to studies from Israel, Italy or Australia. In addition, the pathophysiology, heritability and molecular mechanisms of co-allergies remain unclear and furthers studies are needed. FPIES to fish is mainly described in older children and adults, and is relatively common in Italy and Spain.Citation40,Citation52 Of note, in most of the cases (65%) children react to one single fish.Citation52

Diagnosis

Diagnosis of FPIES may be difficult, particularly due to the lack of specific biomarkers to confirm or exclude the diagnosis. Indeed, FPIES is a clinical diagnosis, mainly based on typical clinical manifestations, after exclusion of other causes. Currently, there are no fully validated diagnostic criteria for FPIES. The different proposed diagnostic criteria are detailed in . The more recent diagnostic criteria have been adapted from the initial criteria proposed in 1978 by Powell, to include the acute phenotype of FPIES.Citation18 Basically, the infant/child should present with typical digestive symptoms that resolve after avoidance of the incriminated food. The reexposition to the incriminated should lead to reappearance of clinical signs. Symptoms must be limited to the digestive tract and IgE-mediated symptoms should be excluded.Citation53

Table 3 Diagnostic criteria FPIES

A positive OFC has been part of diagnostic criteria for a long time. However, in clinical practice a confirmatory OFC is not performed in children with several clear FPIES reactions. In fact, at the present time, common practice is to diagnose FPIES without confirmatory OFC in patients experiencing 2 or more typical episodes.Citation6 When OFC is performed, the interpretation is usually based on Powell’s diagnostic criteria.Citation54 A revision of these criteria has also been proposed, which focus on clinical aspects (especially vomiting) and blood testing (leukocytosis) over stool analysis.Citation55 Indeed, diarrhea is present only in a small proportion of patients, and stool analyses are not routinely performed in most reference centers.

Of note, an OFC should always be performed in an appropriate setting, particularly with a trained team and emergency drugs available.Citation55,Citation56 A peripheral intravenous (PIV) line is historically recommended, but its utility remains debated, particularly in patients with mild initial reaction.Citation7,Citation57,Citation58 Although it has been found that up to 15% of patients developed hypotension,Citation10 the majority of studies were performed in tertiary allergic medical centers, treating potentially more complex and severe cases. In comparison, Katz et al, treated successfully 28 reactions during OFC with simple oral rehydration, without any case of hypotension reported.Citation7,Citation57 The need for PIV access should be therefore carefully evaluated and let to the physician evaluation.

To date, there is no consensus on the optimal protocols for OFC in FPIES patients. Recommendations vary between the administration of one (full) single dose up to 3 increasing portions (0.06–0.6 g/kg).Citation20 A lower dose should be considered in patients who presented with a severe initial reaction. Skin prick and/or specific IgE measurement are recommended before performing OFC because of the potential risk of an IgE-mediated allergy.Citation48 In case of IgE mediated FA, the OFC protocol should be adapted to an IgE-mediated allergy protocol.Citation1,Citation48

Some authors have found positive patch tests to the specific food antigen.Citation21Citation27,Citation31 Nevertheless, others have shown that patch tests have a poor predictive value (75%) and could be falsely negative in up to 45% in patients with FPIES. Thus, they are not routinely recommended.Citation11,Citation22Citation29 Similarly, measurements of IgG and IgG4 antibodies in blood are not recommended. It is important to note that because diagnostic criteria focus on systemic impairment, local intestinal evaluation via endoscopy, and histological findings in FPIES remains poorly characterized. Although not recommended for routine diagnosis, endoscopy might be helpful in cases of unclear diagnosis to help rule out other conditions. In addition for research purposes, studies assessing macroscopic or histological changes in FPIES would be very useful.Citation59

Differential diagnosis

As clinical features of FPIES are rather nonspecific, the differential diagnosis is extensive as shown in . Mehr et al, reported that a diagnosis is established in only 11% of patients presenting with an isolated acute episode, whereas the rest received no diagnosis or a misdiagnosis, such as viral infection or sepsis.Citation5,Citation56

Table 4 Clinical features of FPIES and its differential diagnosis

Acute FPIES symptoms are very similar to infectious disease.Citation4,Citation54 Viral gastroenteritis is often suspected during the first episode. Hypotension and lethargy in infant can falsely lead to a diagnosis of sepsis.Citation60 In the presence of hypotension, anaphylaxis is more often suspected than FPIES. In severe cases, FPIES can mimic an acute surgical abdomen.Citation61 Of note, although specific blood tests are not necessary for FPIES diagnosis, they might be needed to eliminate sepsis, a metabolic disorder or a congenital methemoglobinemia for example.

Regarding the chronic form of FPIES, congenital mucosa abnormalities or necrotizing enteropathy could present with similar symptoms, and need to be ruled out in neonates and especially in preterm children. The chronic form of FPIES is clinically close to other food allergies such as celiac disease, FP or FPIAP.Citation10 FPIAP appears often in exclusively breastfed and well-being infants in the first month of life, with isolated bloody stools. In this case, anemia can be the characteristic laboratory finding. FPE is characterized by inflammation localized in the small bowel causing malabsorption, leading to diarrhea, intermittent emesis and/or FTT. In most cases, FPIAP and FPE occur after ingestion of CM or soy formula.Citation62 Moreover, primary eosinophilic GI disorders (EGIDs) may present with a phenotypic overlap. In addition, histological findings in EGIDs are also characterized by eosinophilic and mast cell infiltration. Thus, distinction between these disorders might be difficult in clinical practice, and from a physiopathological point of view, it is not clear if they are distinct disorders and if they are part of continuum.

Natural history

FPIES appears most frequently in the first months of life but can manifest at any age.Citation2,Citation42 FPIES to CM or soy begins in early infancy from several days to 4 weeks after the introduction of infant formula. In an Israeli population-based birth cohort the median onset of CM-induced FPIES onset was 30 days and all patients presented before 6 months.Citation20 In breastfed infants the delay of onset seems to be longer. FPIES to solid-food usually begins in older infants because of later introduction into the diet, in general after 4 months of age.Citation2,Citation14

FPIES resolves at different ages according to the food involved and the population.Citation6 Thus, in an American study CM-FPIES resolved in 20% of cases by 3 years of age, while a Korean cohort showed >60% resolution by 10 months of age, and an Israeli birth cohort showed 90% resolution by the age of 30 months.Citation2,Citation7,Citation8 Similar rates were found for soy FPIES in the American cohort with 20% of resolution by 3 years of age, and again 90% of the Korean children showing resolution by 10 months of age.Citation8 Those differences are probably explained by inclusion of different phenotype in the different studies, that is, more severe cases in American studies based on tertiary center. The natural history of FPIES to solid foods is less known and data are sparse. It has been found that 65.5% of children reactive to grains resolved their FPIES by 5 years of age, whereas those children who reacted to meat and fish/shellfish took more time: 50% and 0% at 5 years of age, respectively.Citation2 FPIES to seafood seems to last longer than for other solids.Citation12,Citation50,Citation63 Of note, it has been suggested that patients with atypical FPIES (i.e., with positive food-specific IgE to the incriminated food) appear to have a more protracted course.Citation2,Citation12

Management

The management of FPIES is still controversial in many aspects and mostly empiric, but the international guidelines are due out soon (Nowak-Wegrzyn et al, JACI, in press). In general, management of these patients has to include acute phase treatment as well as maintenance therapy in order to avoid recurrence of acute relapse, but also prevention of nutritional deficiencies.Citation3,Citation12,Citation29

Acute management

Supportive therapy

Fluid repletion is the first line and the cornerstone of management. As acute FPIES mostly occurs at home, acute management starts there via oral hydration. Medical management is essential either in an outpatient clinic or in hospital to discuss intravenous volume repletion with normal saline bolus (20 mL/kg, that should be repeated if needed). Amines supportive therapy will be rarely needed, as the evolution is in most case quickly favorable after rehydration. Of note, although the use of epinephrine may be indicated to treat hypotension, it has no effect on preventing emesis.Citation10,Citation42

Steroids therapy

As local inflammation is suggested to be part of the pathophysiology of FPIES, a single dose of intravenous (IV) methylprednisone Solumedrol® (1–2 mg/kg up to 60–80 mg) in case of severe reactions may be considered.Citation10 It can also play a role in the volume supportive therapy. But the utility of corticosteroids in FPIES has not been clearly demonstrated.

Ondansetron

Based on small case series reporting effectiveness of ondansetron injection during acute FPIES, its administration may be considered.Citation64Citation66 Ondansetron, a 5-HT3 receptor antagonist has antiserotoninergic effect, that may play a role in gut secretion and motility via the afferent nerves.Citation62,Citation65,Citation66 Ondansetron seems not only to reduce or prohibit nausea and vomiting, but also the development of diarrhea.Citation62,Citation65,Citation66 The recommended dose ranges from 0.1 to 0.15 mg/kg administered IV or intramuscular (maximum single dose 16 mg) and is generally well tolerated. Sublingual administration can also be discussed. Nevertheless, contraindications (i.e., prolonged QT-interval and arrhythmia) existCitation10 and further large prospective and multicentric studies confirming its efficacy and safety are needed.

Maintenance therapy

After review of the acute episode, an emergency treatment letter including teaching of clinical features and management of acute FPIES episode should be provided to the parents/patient and can be shown in case of emergency to the physician. Indeed, formal education of the parents and, if appropriate, the child or adolescent is very important in order to avoid misdiagnosis of future episodes.

Maintenance therapy should include discussion of the following key points:

Elimination of the offending food protein

The diet until reintroduction under medical supervision is the rule. Avoidance of products with precautionary labeling (e.g., “can contain traces of ”, “run the same line”) is usually not necessary.Citation67 The success of the avoidance diet will also depend on whether they have seen a dietitian with experience in dealing with FPIES or not, as well as commercial availability of food, parental resources, cooking skills in the family, the number of allergens to avoid and/or the period of avoidance required.Citation3 Indeed, these infants/children may benefit from nutritional evaluation and guidance, but also from laboratory assessment of iron, calcium, and vitamin D status. Supplementation may be then indicated and prescribed to these patients. Future studies should systematically evaluate the prevalence of feeding difficulties, poor weight gain, and growth and nutrient deficiencies for preventive intervention in this at-risk population. Of note, growth monitoring of those patients is particularly important.

Breastfeeding

The majority of infants with FPIES tolerate the incriminated allergen through breastfeeding without the need for a maternal eviction diet.Citation20,Citation68 Therefore, breastfeeding should be encouraged and routine avoidance of allergenic food is not recommended in breastfeeding mothers.Citation3 Regarding patients with persistent symptoms, particularly FTT, empiric eviction of allergens by the mother might be indicated.Citation69 The ideal length of the eviction trial is not known, probably several days up to 4 weeks appear sufficient.Citation70

The choice of formula

The recommendations about formula in young infants with FPIES to CM who cannot be breastfed vary. While the guidelines from the World Allergy Organization recommend the use of an extensively hydrolyzed formula (EHF), the European society of pediatric gastroenterology, hepatology, and nutrition advise amino acid-based formula (AAF) for infants with FPIES, especially those with FTT, as AAF may confer advantages for catch up growth.Citation3,Citation70,Citation71 Of note, it has been shown that ~10%–20% of FPIES patients will require an AAF.Citation2,Citation20 A reasonable approach would be to initiate treatment with EHF, and in those patients who do not display satisfactory symptom relief or catch up growth within 2 weeks, it would be necessary to switch to AAF.Citation2,Citation20 For patients with severe FPIES an AAF might be the optimal initial choice. As the palatability of the EHF formula is different, infants and children may decrease their daily volume of intakes and can be at risk for deficiency of calcium and other minerals and vitamins. This requires follow-up and supplementation in case of deficiency.Citation72

Heated or baked food proteins

Current recommendations suggest avoiding all forms of the offending allergen, including baked and processed food. Indeed, there is only one report suggesting tolerance of small amount of the cooked offending food.Citation72 But the introduction of baked foods under medical observation might be discussed if the family is interested, particularly baked egg or milk in patients with FPIES to egg or milk, respectively.

Timing and setting of reintroduction of the offending food

The actual recommendation based on US and Western Europe approach is an OFC 12–18 months after the last reaction. However, as previously discussed, the natural history of FPIES varies according the food incriminated, the population studied and probably the severity of the initial reaction. Thus, the decision to attempt reintroduction in order to assess tolerance acquisition should take all these factors into account. Shorter intervals might be adequate for patients with milder forms and those reacting to CM or soy, while longer intervals may be needed for patients with more severe form and those reacting to solids. However, further well-designed studies are needed to determine the optimal timing of OFC to assess tolerance acquisition.

General nutritional recommendations for infants and children with different types of FPIES are described in the following sections.Citation73

In infants with CM FPIES

Avoidance of soy formula is usually recommended during the first months of life because of possible co-allergies with varying frequency in different countries.Citation2,Citation10,Citation14,Citation74 A reason able approach would be to propose an OFC after 6 months to assess tolerance of soymilk formula in those patients. In patients with CM FPIES, the risk to develop FPIES to solids exists, and it is usually recommend to start between 6 and 12 months of age with yellow fruits or vegetables unlikely to cause FPIES, followed by meats and cereal grains.Citation10 As there is a risk of successive FPIES on solid food, the introduction of solids known to cause solid FPIES such as grains, rice, and fish should be initiated with caution. It can be performed in a medical facility (particularly for severe CM FPIES) or at home at the discretion of the treating physician and with the supervision of a dietician who can support the whole weaning process and avoid unnecessary restriction. We recommend the introduction of one food per week. Introduction of any other animal milk, especially goat or sheep milk, is not recommended due to a higher risk of cross reactivity proteins.Citation30,Citation77

Infants with soy FPIES

Like infants with CM FPIES, infants with soy FPIES are at risk to react to CM formula as well as to solid foods, known to cause FPIES. Therefore, the recommendations are similar to those for infants with CM FPIES.

Solid FPIES

Infants/children with grains FPIES: Children with FPIES to rice, oat, barley or wheat are at risk to present symptoms after the ingestion of other grains.Citation2,Citation20 Because of their vulnerability, these patients might benefit from delayed introduction of grains beyond the first year of life. Introduction should be conducted under medical observation. CM and soy, if not already part of the child’s diet, should be introduced after 6 months of age and under medical observation as co-allergies have been reported. The ingestion of all food already introduced and not responsive of the symptoms should be continued.

Infants/children with fish and/or shellfish FPIES: FPIES to fish follows the same guidelines than others solid food FPIES but with some specificities. It is a common solid-food FPIES in Italy and Spain.Citation52 Similarly to IgE-mediated fish or shellfish allergy, as there are potential co-reactions with other fishes or shellfish, respectively, an OFC should be performed to assess tolerance. Of note, there is little data on resolution of FPIES to fish and seafood in older children and adults, and reintroduction should be considered in these patients, with a longer delay than for patients with FPIES to CM or soy.

Conclusion

FPIES is a non-IgE-GI-FA with heterogeneous features and is not a rarity in infants and children. It can potentially present with severe reactions requiring cautious management in short and long term. Diagnosis relies on medical history and typical symptoms like vomiting, pallor, lethargy, and diarrhea resolving after the elimination of the offending food from the infant’s/child’s diet and might relapse after OFC. The natural history is usually good in the vast majority of the case, supporting the reevaluation by OFC every 12–18 months. But the possible switch to IgE-FA seems to predispose to a more prolonged phenotype.

Avoiding the offending food requires education of the family for the exposed patient. Because of the possible prolonged evolution before and after diagnosis, a multidisciplinary approach is required between allergists, gastroenterologists and dieticians, specialized nurses, and caregivers. Although some new recommendations have emerged those past years, new international guidelines are currently needed to improve the management of those patients.Citation73

Acknowledgments

The authors thank Dr Valérie McLin for her critical review of the manuscript and English-language editing.

Disclosure

The authors report no conflicts of interest in this work.

References

  • SichererSBurksAWSampsonHAClinical features of acute allergic reactions to peanut and tree nuts in childrenPediatrics19981021e69651458
  • CaubetJCFordLSSicklesLClinical features and resolution of food protein-induced enterocolitis syndrome: 10-year experienceJ Allergy Clin Immunol2014134238238924880634
  • VenterCGroetchMNutritonal management of food protein-induced enterocolitis syndromeCurr Opin Allergy Clin Immunol201414325526224699338
  • MehrSKakakiosAMFrithKKempASFood protein-induced enterocolitis syndrome: 16-year experiencePediatrics20091233459464
  • MehrSFrithKCampbellDEEpidemiology of food protein induced enterocolitis syndromeCurr Opin Allergy Clin Immunol201414320821624686277
  • Miceli SopoSGiorgoVIaconoINovembreEMoriFOnesimoRA multicenter retrospective study of 66 Italian children with food protein-induced enterocolitis syndrome: different management for different phenotypesClin Exp Allergy20124281257126522805473
  • KatzYGoldbergMRRajuanNCohenALeshnoMThe prevalence and natural course of food protein-induced enterocolitis syndrome to cow’s milk: a large-scale, prospective population-based studyJ Allergy Clin Immunol2011127364765321377033
  • HwangJSohnSMKimAProspective follow-up oral food challenge in food protein-induced enterocolitis syndromeArch Dis Child200994642542818829623
  • RubinMIAllergic intestinal bleeding in the newborn: a clinical syndromeMed Sci1940200385390
  • Nowak-WęgrzynAKatzYMehrSSKoletzkoSNon-IgE-mediated gastrointestinal food allergyJ Allergy Clin Immunol201513551114112425956013
  • GarciaMRJimenez DiazFFood protein-induced enterocolitis syndrome (FPIES): our experienceJ Allergy Clin Immunol20121292AB34
  • Nowak-WegrzynASampsonHAWoodRSichererSFood protein-induced enterocolitis syndrome caused by solid food proteinsPediat-rics20031114829835
  • ShodaTIsozakiAKawanoYFood protein-induced gastrointestinal syndromes in identical fraternal twinsAllergol Int201160110310821252620
  • RuffnerMRuymannKBarniSCianferoniABrwon-WhitehornTSpergelJFood protein-induced enterocolitis-syndrome: insights from review of a large referral populationJ Allergy Clin Immunol201314343349
  • MehrSKakakiosAMKempASRice: a common and severe cause of food protein-induced enterocolitis syndromeArch Dis Child200994322022318957470
  • SichererSEigenmannPASampsonHAClinical features of food protein-induced enterocolitis syndromeJ Pediatr199813322142199709708
  • PowellGKEnterocolitis in low-birth-weight infants associated with milk and soy protein intoleranceJ Pediatr1976885840844944766
  • PowellGKMilk- and soy-induced enterocolitis of infancy. Clinical features and standardization of challengeJ Pediatr1978934553560568171
  • SichererSHFood protein-induced enterocolitis syndrome: case presentations and management lessonsJ Allergy Clin Immunol2005115114915615637562
  • KatzYGoldbergMRNatural history of food protein-induced enterocolitis syndromeCurr Opin Allergy Clin Immunol201414322923924686278
  • TanJASmithWBNon-IgE-mediated gastrointestinal food hypersensitivity syndrome in adultsJ Allergy Clin Immunol Pract20142335535724811033
  • Van SickleGPowellGKMcDonaldPGoldblumRMilk- and soy protein-induced enterocolitis: evidence for lymphocyte sensitization to specific food proteinsGastroenterology1985886191519214039696
  • FoggMIBrown-WhitehornTAPawlowskiNASpergelJMAtopy patch test for the diagnosis of food protein-induced enterocolitis syndromePediatr Allergy Immunol200617535135516846453
  • ShekLPBardinaLCastroRSampsonHABeyerKHumoral and cellular responses to cow milk proteins in patients with milk-induced IgE-mediated and non-IgE-mediated disordersAllergy200560791291915932382
  • BenlounesNDupontCCandalhCThe threshold for immune cell reactivity to milk antigens decreases in cow’s milk allergy with intestinal symptomsJ Allergy Clin Immunol19969847817898876554
  • KarlssonMRugtveitJBrandtzaegPAllergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow’s milk allergyJ Exp Med2004199121679168815197226
  • HoffmanKMHoDGSampsonHAEvaluation of the usefulness of lymphocyte proliferation assays in the diagnosis of allergy to cow’s milkJ Allergy Clin Immunol19979933603669058692
  • ScarparrottaADi PilloSConsilvioNPUsefulness of Atopy Patch Test on a child with milk protein-induced enterocolitis syndrome: a case reportInt J Immunopathol Pharmacol201326379580024067480
  • HeymanMDarmonNDupontCMononuclear cells from infants allergic to cow’s milk secrete tumor necrosis factor alpha, altering intestinal functionGastroenterology19941066151415238194697
  • Miceli SopoSIaconoIGrecoMMontiGClinical management of food protein-induced enterocolitis syndromeCurr Opin Allergy Clin Immunol201414324024524686275
  • CaubetJCNowak-WegrzynACurrent understanding of the immune mechanisms of food protein-induced enterocolitis syndromeExpert Rev Clin Immunol20117331732721595598
  • CaubetJCBencharitiwongRRossASampsonHABerinMCNowak-WegrzynAHumoral and cellular responses to casein in patients with food protein-induced enterocolitis to cow’s milkJ Allergy Clin Immunol2017139257258327545065
  • MoriFBarniSCianferoniAPucciNde MartinoMNovembreECytokine expression in CD3+ cells in an infant with food protein-induced enterocolitis syndrome (FPIES): case reportClin Dev Immunol2009200967938120011655
  • McDonaldPJGoldblumMRVan SickleGJPowellGKFood protein-induced enterocolitis: altered antibody response to ingested antigenPediatr Res19841887517556540862
  • FontaineJLNavarroJSmall intestinal biopsy in cows milk protein allergy in infancyArch Dis Child19755053573621190811
  • ChungHLHwangJBKwonYDParkMShinWParkJDeposition of eosinophil-granule major basic protein and expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in the mucosa of the small intestine in infants with cow’s milk-sensitive enteropathyJ Allergy Clin Immunol199910361195120110359906
  • BanzatoCPiacentiniGLComberiatiPMazzeiFBonerALPeroniDGUnusual shift from IgE-mediated milk allergy to food protein-induced enterocolitis syndromeEur Ann Allergy Clin Immunol201345620921124619083
  • KonstantinouGNBencharitiwongRGrishinAThe role of casein-specific IgA and TGF-β in children with food protein-induced enterocolitis syndrome to milkPediatr Allergy Immunol201425765165625283440
  • LevyYDanonYLFood protein-induced enterocolitis syndrome–not only due to cow’s milk and soyPediatr Allergy Immunol200314432532912911514
  • RemonZAlonsoLEMartinFMartinezMFood protein-induced enterocolitis syndrome caused by fishAllergol Immunopathol (Madr)200533631231616371218
  • HsuPMehrSEgg: a frequent trigger of food protein-induced enterocolitis syndromeJ Allergy Clin Immunol2013131124124223069493
  • FernandesBNBoyleRJGoreCSimpsonACustovicAFood protein-induced enterocolitis syndrome can occur in adultsJ Allergy Clin Immunol201213051199120022835404
  • BorchersSDLiBUFriedmanRAMcClungHJRice-induced anaphylactoid reactionJ Pediatr Gastroenterol Nutr19921533213271432472
  • CavataioFCarroccioAMontaltoGIanconoGIsolated rice intolerance: clinical and immunologic characteristics in four infantsJ Pediatr199612845585608618193
  • VandenplasYEdelmanRSacréLChicken-induced anaphylactoid reaction and colitisJ Pediatr Gastroenterol Nutr19941922402417815248
  • Arik YilmazECavkaytarOUysal SoyerOSackesenCEgg yolk: an unusual trigger of food protein-induced enterocolitis syndromePediatr Allergy Immunol201425329629724289267
  • CaubetJCNowak-WegrzynAFood protein-induced enterocolitis to hen’s eggJ Allergy Clin Immunol201112861386138821851972
  • CaubetJCSzajewskaHShamirRNowak-WęgrzynANon IgE-mediated gastrointestinal food allergies in childrenPediatr Allergy Immunol201728161727637372
  • Australian Institute of Health and Welfare Canberra2010Australian National Infant Feeding Survey. Indicator results2011 Available from: http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=10737420925Accessed May 15, 2017
  • Grummer-StrawnLMScanlonKSFeinSBInfant feeding and feeding transitions during the first year of lifePediatrics2008122Suppl 2S36S4218829829
  • HwangJBKangKJKangYNKimASProbiotic gastrointestinal allergic reaction caused by Saccharomyces boulardiiAnn Allergy Asthma Immunol20091031878819663138
  • Miceli SopoSMonacoSBadinaLFood protein-induced enterocolitis syndrome caused by fish and/or shellfish in ItalyPediatr Allergy Immunol201526873173626287446
  • LeonardSANowak-WegrzynAClinical diagnosis and management of food protein-induced enterocolitis syndromeCurr Opin Pediatr201224673974523042254
  • PowellGKFood protein-induced enterocolitis of infancy: differential diagnosis and managementCompr Ther19861222837
  • Nowak-WegrzynAFood protein-induced enterocolitis syndrome and allergic proctocolitisAllergy Asthma Proc201536317218425976434
  • BoyceJAssa’adABurksAWGuidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel ReportJ Allergy Clin Immunol201012661105111821134568
  • JärvinenKNowak-WegrzynAA. Food protein-induced enterocolitis syndrome: current management strategies and review of the literatureJ Allergy Clin Immunol Pract20131431732224565536
  • MuraroAWerfelTHoffmann-SommergruberKEAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergyAllergy20146981008102524909706
  • WangJFiocchiAUnmet needs in food protein-induced enterocolitis syndromeCurr Opin Allergy Clin Immunol201414320620724755920
  • BarascheJStollarFBermannMCaubetJCSeverely altered-consciousness status and profuse vomiting in infants: food protein–induced enterocolitis syndrome (FPIES) a challenging diagnosisPediatr Emerg Care Epub2016106
  • JayasooriyaSFoxATMurchSHDo not laparotomize food-protein-induced enterocolitis syndromePediatr Emerg Care200723317317517413436
  • HolbrookTKeetCAFrischmeyer-GuerrerioPAWoodRAUse of ondansetron for food protein-induced enterocolitis syndromeJ Allergy Clin Immunol201313251219122023890754
  • LeonardSANowak-WegrzynAFood protein-induced enterocolitis syndrome: an update on natural history and review of managmentAnn Allergy Asthma Immunol201110729510121802016
  • BerinMCImmunopathophysiology of food protein-induced enterocolitis syndromeJ Allergy Clin Immunol2016135511081113
  • Miceli SopoSBattistaAGrecoMMonacoSOndansetron for food protein-induced enterocolitis syndromeInt Arch Allergy Immunol2014164213713924993542
  • ManeSKHollisterMEBahnaSLFood protein-induced enterocolitis syndrome to trivial oral mucosal contactEur J Pediatr2014173121545154723715655
  • KhannaNPatelKFPIES: reviewing the management of food protein-induced enterocolitis syndromeCase Rep Pediatr20162016162182727051548
  • KayaAToyranMCivelekEMısırlıogluEDKırsaçlıogluCTKocabaşCNFood protein-induced enterocolitis syndrome in two exclusively breastfed infantsPediatr Allergy Immunol201627774975027288868
  • NiggemannBBinderCDupontCHadjiSArvolaTIsolauriEProspective, controlled, multicenter study on the effect of an amino-acid-based formula in infants with cow’s milk allergy/intolerance and atopic dermatitisPediatr Allergy Immunol20011227882
  • HillDJMurchSHRaffertyKWallisPGreenCJThe efficacy of amino acid-based formulas in relieving the symptoms of cow’s milk allergy: a systematic reviewClin Exp Allergy200737680882217517094
  • FiocchiABrozekJSchunemannHWorld Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow’s Milk Allergy (DRACMA) guidelinesPediatr Allergy Immunol201021Suppl 211125
  • Miceli SopoSBuonsensoDMonacoSCroccoSLongoGCalvaniMFood protein-induced enterocolitis syndrome (FPIES) and well cooked foods: a working hypothesisAllergol Immunopathol (Madr)201341534634823141755
  • Nowak-WęgrzynAChehadeMGroetchMESpergelJMInternational consensus guidelines for the diagnosis and management of food protein-induced enterocolitis syndrome: Executive summary-Workgroup Report of the Adverse Reactions to Foods Committee, American Academy of Allergy, Asthma & ImmunologyJ Allergy Clin Immunol201713941111112628167094
  • Miceli SopoSGrecoMMonacoSTripodiSCalvaniMFood protein-induced enterocolitis syndrome, from practice to theoryExpert Rev Clin Immunol20139870771523971749
  • SerafiniSBergmannMMNowak-WęgrzynAEigenmannPACaubetJCA case of food protein–induced enterocolitis syndrome to mushrooms challenging currently used diagnostic criteriaJ Allergy Clin Immunol Pract20153113513725577639
  • BarascheJStollarFBergmannMMCaubetJCSeverely altered-consciousness status and profuse vomiting in infants: Food Protein-Induced Enterocolitis Syndrome (FPIES) a challenging diagnosisPediatr Emerg Care Epub2016106
  • Nowak-WegrzynAChehadeMGroetchMEInternational consensus guidelines for diagnosis and management of food protein-induced enterocolitis syndrome: Executive summary-Workgroup Report of the Adverse Reactions to Foods Committee, American Academy of Allergy, Asthma & ImmunologyJ Allergy Clin Immunol Epub201724